Adial Pharmaceuticals, Inc.
ADIL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513525
In the last 90 days, Adial Pharmaceuticals, Inc. insiders filed 3 open-market purchases and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $334.6K in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Adial Pharmaceuticals, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- −8 vs. Q4 2025
- Shares held
- 35.6K
- −99.7K (−73.7%) vs. Q4 2025Converted for a 1-for-25 split
- Total value
- $63.8K
- −$680.3K (−91.4%) vs. Q4 2025
- New holders
- 4
- 5 more added
- Sold out
- 12
- 4 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADIL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $334.6K |
| Q1 2026 | 15 | $63.8K |
| Q4 2025 | 24 | $778.4K |
| Q3 2025 | 17 | $214.8K |
| Q2 2025 | 17 | $70.8K |
| Q1 2025 | 14 | $152.7K |
| Q4 2024 | 15 | $298.1K |
| Q3 2024 | 12 | $195.9K |
| Q2 2024 | 16 | $328.0K |
| Q1 2024 | 16 | $236.2K |
| Q4 2023 | 17 | $495.3K |
| Q3 2023 | 11 | $164.2K |
| Q2 2023 | 21 | $488.2K |
| Q1 2023 | 23 | $876.9K |
| Q4 2022 | 23 | $359.2K |
| Q3 2022 | 28 | $692.1K |
| Q2 2022 | 26 | $2.27M |
| Q1 2022 | 23 | $6.38M |
| Q4 2021 | 24 | $3.61M |
| Q3 2021 | 21 | $5.50M |
| Q2 2021 | 19 | $3.15M |
| Q1 2021 | 20 | $1.95M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Adial Pharmaceuticals, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 24,249 | $43.4K | 0.00% | +18,019+289.2% | AddedConverted for a 1-for-25 split |
| Vanguard Fiduciary Trust Co | 5,879 | $10.5K | 0.00% | +5,879 | New |
| Manchester Capital Management LLC | 1,923 | $3.44K | 0.00% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Tower Research Capital LLC (TRC) | 1,356 | $2.43K | 0.00% | +1,302+2,428.0% | AddedConverted for a 1-for-25 split |
| BlackRock, Inc. | 1,110 | $1.99K | 0.00% | 00.0% | UnchangedConverted for a 1-for-25 split |
| UBS Group AG | 542 | $970 | 0.00% | +175+47.8% | AddedConverted for a 1-for-25 split |
| Vanguard Capital Management LLC | 361 | $646 | 0.00% | +361 | New |
| Raffa Wealth Management, LLC | 83 | $149 | 0.00% | −1−0.9% | ReducedConverted for a 1-for-25 split |
| Morgan Stanley | 50 | $90 | 0.00% | +50+13,788.9% | AddedConverted for a 1-for-25 split |
| SBI Securities Co., Ltd. | 47 | $84 | 0.00% | +1+1.5% | AddedConverted for a 1-for-25 split |
| Caitong International Asset Management Co., Ltd | 15 | $27 | 0.00% | +15 | New |
| Wells Fargo & Company | 6 | $11 | 0.00% | −0−6.3% | ReducedConverted for a 1-for-25 split |
| Northwestern Mutual Wealth Management Co | 4 | $7 | 0.00% | +4 | New |
| Harbour Investments, Inc. | 3 | $5 | 0.00% | −1−24.2% | ReducedConverted for a 1-for-25 split |
| Abound Wealth Management | 1 | $2 | 0.00% | −0−7.4% | ReducedConverted for a 1-for-25 split |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −102,178−100.0% | Sold outConverted for a 1-for-25 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −8,785−100.0% | Sold outConverted for a 1-for-25 split |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −4,874−100.0% | Sold outConverted for a 1-for-25 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −2,639−100.0% | Sold outConverted for a 1-for-25 split |
| Virtu Financial LLC | 0 | $0 | 0.00% | −2,553−100.0% | Sold outConverted for a 1-for-25 split |
| XTX Topco Ltd | 0 | $0 | 0.00% | −2,084−100.0% | Sold outConverted for a 1-for-25 split |
| StoneX Group Inc. | 0 | $0 | 0.00% | −778−100.0% | Sold outConverted for a 1-for-25 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −683−100.0% | Sold outConverted for a 1-for-25 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −483−100.0% | Sold outConverted for a 1-for-25 split |
| Private Management Group Inc | 0 | $0 | 0.00% | −400−100.0% | Sold outConverted for a 1-for-25 split |
| Bank of America Corp | 0 | $0 | 0.00% | −8−100.0% | Sold outConverted for a 1-for-25 split |
| Citigroup Inc | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-25 split |
| Vanguard Group Inc | – | – | – | – | Not filed |